CYP19A1 and cancer: In HR+ breast cancer, aromatase is frequently overexpressed in breast endothelial cells and the surrounding stroma leading to local estrogen synthesis within the tumor microenvironment, thus stimulating cancer growth through estrogen receptor activation (4).